SCHEMBL6206093

SCHEMBL6206093

CC1CC=C2C=CN=C2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35518 0.58
SCHEMBL6591843 0.57
SCHEMBL4797212 0.57
SCHEMBL19457314 0.57
SCHEMBL1658305 0.57
SCHEMBL9499109 0.54
SCHEMBL24521821 0.53 NISCH (0.39)
SCHEMBL13924888 0.52
SCHEMBL13261993 0.52
SCHEMBL1782987 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103764143-B Lipoxygenase inhibitors 斯坦福国际咨询研究所 2017-05-03 CN disclosed
CN-103764143-A Lipoxygenase inhibitors STANFORD RES INST INT 2014-04-30 CN disclosed
EP-1530572-A2 ANALOGS OF INDOLE-3-CARBINOL METABOLITES AS CHEMOTHERAPEUTIC AND CHEMOPREVENTIVE AGENTS Sri International (US) 2005-05-18 EP disclosed
WO-2004018475-A2 ANALOGS OF INDOLE-3-CARBINOL METABOLITES AS CHEMOTHERAPEUTIC AND CHEMOPREVENTIVE AGENTS SRI INTERNATIONAL (US) 2004-03-04 WO disclosed